In Brief This Week: Biocept, Quest, Agilent, MDxHealth, OpGen, More
News items for the week of May 15, 2023.
Top Five Articles on 360Dx Last Week: Curative Spinoff Dx Firm; Pfizer Buys Lucira Health; and More
Last week, readers were most interested in a story about Sensible Diagnostics, which will commercialize a 10-minute point-of-care PCR testing platform.
Quest Diagnostics to Acquire Liquid Biopsy Firm Haystack Oncology for up to $450M
The lab testing giant will add Haystack's minimal residual disease technology to its suite of genomic and other clinical services.
Quest Adds to Cancer Portfolio With $450M Buy of Haystack Oncology; Q1 Revenues Down 11 Percent
The firm said the acquisition let it move into the "fast growing" MRD space and round out its offerings in cancer screening, pathology, and sequencing.
Industry figures have highlighted the untapped value in lab data, but translating that value into actual revenue requires overcoming a number of challenges.
Apr 20, 2023
Feb 1, 2023
360Dx Top 30 Starts the Year up 1 Percent
Jan 3, 2023
360Dx Top 30 Drops 37 Percent in 2022
Dec 21, 2022